About 11 results found for searched term "W-5 hydrochloride" (0.054 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1929 | GW3965 hydrochloride | Liver X Receptor |
| GW3965 HCl | ||
| GW3965 hydrochloride is a selective, orally active non-steroidal synthetic liver X receptor (LXR) agonist. | ||
| M6050 | Venlafaxine HCl | 5-HT Receptor |
| Wy 45030 hydrochloride | ||
| Venlafaxine HCl is an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI), used to treat major depressive disorder (MDD), generalised anxiety disorder (GAD), panic disorder and social phobia. | ||
| M7480 | W-5 hydrochloride | Others |
| W-5 hydrochloride is a calmodulin antagonist. | ||
| M8851 | WAY 161503 hydrochloride | Others |
| The 5-HT2C receptors have been implicated in conditions including obesity, anxiety, depression, OCD, schizophrenia, migraine, nociception and erectile dysfunction. | ||
| M8856 | WAY-100135 dihydrochloride | 5-HT Receptor |
| WAY-100135 dihydrochloride is a potent, selective 5-HT1A receptor antagonist (IC50 = 15 nM). | ||
| M13534 | WEHI-539 hydrochloride | Bcl-2 |
| WEHI-539 hydrochloride is a selective inhibitor of Bcl-XL with an IC50 of 1.1 nM. | ||
| M21198 | ZZW-115 hydrochloride | Apoptosis |
| ZZW-115 is a potent NUPR1 inhibitor with a Kd of 2.1 μM and an IC50 of 0.42 μM in Hep2G cells and 7.75 μM in SaOS-2 cells. zZW-115 showed significant antitumor activity through interaction with NUPR1. | ||
| M28785 | MW-150 dihydrochloride dihydrate | p38 MAPK |
| MW01-18-150SRM dihydrochloride dihydrate | ||
| MW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. MW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) inhibits the ability of the endogenous p38α MAPK to phosphorylate an endogenous substrate MK2 in activated glia. | ||
| M29024 | MW-150 hydrochloride | p38 MAPK |
| MW01-18-150SRM hydrochloride | ||
| MW-150 hydrochloride (MW01-18-150SRM hydrochloride) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. MW-150 hydrochloride (MW01-18-150SRM hydrochloride) inhibits the ability of the endogenous p38α MAPK to phosphorylate an endogenous substrate MK2 in activated glia. | ||
| M42080 | GW583340 dihydrochloride | EGFR/HER2 |
| GW 583340 dihydrochloride is a potent dual EGFR/ErbB2 tyrosine kinase inhibitor (IC50: 0.01 and 0.014 μM respectively). | ||
| M42142 | GW284543 hydrochloride | MEK |
| GW284543 (UNC10225170) hydrochloride is a selective MEK5 inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
